Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

The association of atrophy in baseline prostate biopsy and lower prostate cancer grade in radical prostatectomy specimens.

Freitas DMO, Andriole GL, Castro-Santamaria R, Freedland SJ, Moreira DM.

Scand J Urol. 2019 Feb 14:1-5. doi: 10.1080/21681805.2018.1551244. [Epub ahead of print]

PMID:
30762450
2.

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.

Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, Vickers AJ.

Eur Urol. 2018 Aug;74(2):197-203. doi: 10.1016/j.eururo.2018.05.003. Epub 2018 May 16.

PMID:
29778349
3.

Development and external validation of a prostate health index-based nomogram for predicting prostate cancer.

Zhu Y, Han CT, Zhang GM, Liu F, Ding Q, Xu JF, Vidal AC, Freedland SJ, Ng CF, Ye DW.

Sci Rep. 2015 Oct 16;5:15341. doi: 10.1038/srep15341.

4.

Early detection of prostate cancer: AUA Guideline.

Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH, Penson DF, Zietman AL.

J Urol. 2013 Aug;190(2):419-26. doi: 10.1016/j.juro.2013.04.119. Epub 2013 May 6.

5.

Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.

Ukimura O, Coleman JA, de la Taille A, Emberton M, Epstein JI, Freedland SJ, Giannarini G, Kibel AS, Montironi R, Ploussard G, Roobol MJ, Scattoni V, Jones JS.

Eur Urol. 2013 Feb;63(2):214-30. doi: 10.1016/j.eururo.2012.09.033. Epub 2012 Sep 25. Review.

PMID:
23021971
6.

The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.

Bañez LL, Albisinni S, Freedland SJ, Tubaro A, De Nunzio C.

World J Urol. 2014 Apr;32(2):323-8. doi: 10.1007/s00345-012-0919-9. Epub 2012 Jul 31.

PMID:
22847453
7.

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.

Roobol MJ, Schröder FH, Hugosson J, Jones JS, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Ankerst D, Bartsch G, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Freedland SJ, Moreira DM, Vickers AJ, Lilja H, Steyerberg EW.

World J Urol. 2012 Apr;30(2):149-55. doi: 10.1007/s00345-011-0804-y. Epub 2011 Dec 28.

8.

The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis.

De Nunzio C, Freedland SJ, Miano L, Finazzi Agrò E, Bañez L, Tubaro A.

Eur J Surg Oncol. 2011 Dec;37(12):1025-9. doi: 10.1016/j.ejso.2011.09.036. Epub 2011 Oct 1.

PMID:
21963050
9.

Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study.

De Nunzio C, Albisinni S, Freedland SJ, Miano L, Cindolo L, Finazzi Agrò E, Autorino R, De Sio M, Schips L, Tubaro A.

Urol Oncol. 2013 Oct;31(7):997-1002. doi: 10.1016/j.urolonc.2011.08.007. Epub 2011 Sep 16.

PMID:
21925906
10.

Predictive value of digital rectal examination for prostate cancer detection is modified by obesity.

Chu DI, De Nunzio C, Gerber L, Thomas JA 2nd, Calloway EE, Albisinni S, Senocak C, McKeever MG, Moreira DM, Tubaro A, Moul JW, Freedland SJ, Bañez LL.

Prostate Cancer Prostatic Dis. 2011 Dec;14(4):346-53. doi: 10.1038/pcan.2011.31. Epub 2011 Jul 5.

11.

The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series.

Moreira DM, Anderson T, Gerber L, Thomas JA, Bañez LL, McKeever MG, Hoyo C, Grant D, Jayachandran J, Freedland SJ.

Cancer Causes Control. 2011 Jul;22(7):977-83. doi: 10.1007/s10552-011-9770-3. Epub 2011 May 12.

PMID:
21562753
12.

Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy.

De Nunzio C, Freedland SJ, Miano R, Trucchi A, Cantiani A, Carluccini A, Tubaro A.

Prostate. 2011 Oct 1;71(14):1492-8. doi: 10.1002/pros.21364. Epub 2011 Feb 25.

PMID:
21360562
13.

Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.

Freedland SJ, Sun L, Kane CJ, Presti JC Jr, Terris MK, Amling CL, Moul JW, Aronson WJ.

BJU Int. 2008 Sep;102(8):969-74. doi: 10.1111/j.1464-410X.2008.07934.x. Epub 2008 Aug 7.

14.

Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.

Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ.

Urology. 2008 May;71(5):787-91. doi: 10.1016/j.urology.2007.11.036. Epub 2008 Feb 11.

PMID:
18267334

Supplemental Content

Loading ...
Support Center